Trials / Conditions / Mucopolysaccharidosis Type I
Mucopolysaccharidosis Type I
7 registered clinical trials studyying Mucopolysaccharidosis Type I — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopoly NCT06519552 | West China Hospital | Phase 1 |
| Active Not Recruiting | Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in P NCT05634512 | Masonic Cancer Center, University of Minnesota | — |
| Completed | MRS to Determine Neuroinflammation and Oxidative Stress in MPS I NCT03576729 | University of Minnesota | — |
| Withdrawn | Biomarker for Hurler Disease (BioHurler) NCT02298712 | CENTOGENE GmbH Rostock | — |
| Completed | Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III NCT03161171 | University Hospital Heidelberg | — |
| Completed | Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI NCT02437253 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 1 / Phase 2 |
| Completed | Longitudinal Studies of Brain Structure and Function in MPS Disorders NCT01870375 | University of Minnesota | — |